UniProt ID | FACE1_HUMAN | |
---|---|---|
UniProt AC | O75844 | |
Protein Name | CAAX prenyl protease 1 homolog | |
Gene Name | ZMPSTE24 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 475 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Nucleus inner membrane Multi-pass membrane protein . |
|
Protein Description | Proteolytically removes the C-terminal three residues of farnesylated proteins. Acts on lamin A/C.. | |
Protein Sequence | MGMWASLDALWEMPAEKRIFGAVLLFSWTVYLWETFLAQRQRRIYKTTTHVPPELGQIMDSETFEKSRLYQLDKSTFSFWSGLYSETEGTLILLFGGIPYLWRLSGRFCGYAGFGPEYEITQSLVFLLLATLFSALTGLPWSLYNTFVIEEKHGFNQQTLGFFMKDAIKKFVVTQCILLPVSSLLLYIIKIGGDYFFIYAWLFTLVVSLVLVTIYADYIAPLFDKFTPLPEGKLKEEIEVMAKSIDFPLTKVYVVEGSKRSSHSNAYFYGFFKNKRIVLFDTLLEEYSVLNKDIQEDSGMEPRNEEEGNSEEIKAKVKNKKQGCKNEEVLAVLGHELGHWKLGHTVKNIIISQMNSFLCFFLFAVLIGRKELFAAFGFYDSQPTLIGLLIIFQFIFSPYNEVLSFCLTVLSRRFEFQADAFAKKLGKAKDLYSALIKLNKDNLGFPVSDWLFSMWHYSHPPLLERLQALKTMKQH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MGMWASLDALWEM --CCCCCCHHHHHCC | 15.98 | - | |
35 | Phosphorylation | WTVYLWETFLAQRQR HHHHHHHHHHHHHHH | 16.62 | - | |
45 | Phosphorylation | AQRQRRIYKTTTHVP HHHHHHHHHCCCCCC | 10.64 | - | |
46 | Ubiquitination | QRQRRIYKTTTHVPP HHHHHHHHCCCCCCC | 36.70 | 21906983 | |
61 | Phosphorylation | ELGQIMDSETFEKSR HHHCCCCCHHHCHHH | 22.58 | - | |
66 | Ubiquitination | MDSETFEKSRLYQLD CCCHHHCHHHCEECC | 36.36 | 21906983 | |
67 | Phosphorylation | DSETFEKSRLYQLDK CCHHHCHHHCEECCH | 21.96 | - | |
233 | Ubiquitination | FTPLPEGKLKEEIEV CCCCCCCCCHHHHHH | 55.51 | 33845483 | |
235 | Ubiquitination | PLPEGKLKEEIEVMA CCCCCCCHHHHHHHH | 57.71 | 22817900 | |
243 | Ubiquitination | EEIEVMAKSIDFPLT HHHHHHHHHCCCCCC | 29.83 | 21963094 | |
244 | Phosphorylation | EIEVMAKSIDFPLTK HHHHHHHHCCCCCCE | 20.18 | 21712546 | |
250 | Phosphorylation | KSIDFPLTKVYVVEG HHCCCCCCEEEEEEC | 20.78 | 18452278 | |
251 | Ubiquitination | SIDFPLTKVYVVEGS HCCCCCCEEEEEECC | 38.97 | 21906983 | |
253 | Phosphorylation | DFPLTKVYVVEGSKR CCCCCEEEEEECCCC | 10.59 | 28152594 | |
259 | Ubiquitination | VYVVEGSKRSSHSNA EEEEECCCCCCCCCC | 68.13 | 21906983 | |
259 | 2-Hydroxyisobutyrylation | VYVVEGSKRSSHSNA EEEEECCCCCCCCCC | 68.13 | - | |
261 | Phosphorylation | VVEGSKRSSHSNAYF EEECCCCCCCCCCEE | 35.82 | 29214152 | |
262 | Phosphorylation | VEGSKRSSHSNAYFY EECCCCCCCCCCEEE | 34.66 | 29214152 | |
264 | Phosphorylation | GSKRSSHSNAYFYGF CCCCCCCCCCEEEEE | 25.71 | 29214152 | |
292 | Ubiquitination | EEYSVLNKDIQEDSG HHHHHHCCHHHCCCC | 52.64 | 29967540 | |
298 | Phosphorylation | NKDIQEDSGMEPRNE CCHHHCCCCCCCCCC | 39.01 | 25159151 | |
300 | Sulfoxidation | DIQEDSGMEPRNEEE HHHCCCCCCCCCCCC | 8.09 | 21406390 | |
310 | Phosphorylation | RNEEEGNSEEIKAKV CCCCCCCHHHHHHHH | 47.68 | 25159151 | |
314 | Ubiquitination | EGNSEEIKAKVKNKK CCCHHHHHHHHHCCC | 45.49 | 21906983 | |
316 | Ubiquitination | NSEEIKAKVKNKKQG CHHHHHHHHHCCCCC | 49.06 | 22817900 | |
318 | Ubiquitination | EEIKAKVKNKKQGCK HHHHHHHHCCCCCCC | 63.44 | 22817900 | |
320 | Ubiquitination | IKAKVKNKKQGCKNE HHHHHHCCCCCCCCH | 40.53 | 23503661 | |
325 | Ubiquitination | KNKKQGCKNEEVLAV HCCCCCCCCHHHHHH | 74.37 | 29967540 | |
325 | Acetylation | KNKKQGCKNEEVLAV HCCCCCCCCHHHHHH | 74.37 | 26051181 | |
341 | Ubiquitination | GHELGHWKLGHTVKN CHHHCHHHHCHHHHH | 38.63 | 29967540 | |
423 | 2-Hydroxyisobutyrylation | FQADAFAKKLGKAKD HCHHHHHHHHCCHHH | 41.92 | - | |
427 | Acetylation | AFAKKLGKAKDLYSA HHHHHHCCHHHHHHH | 63.80 | 12435105 | |
429 | Malonylation | AKKLGKAKDLYSALI HHHHCCHHHHHHHHH | 52.32 | 26320211 | |
429 | Ubiquitination | AKKLGKAKDLYSALI HHHHCCHHHHHHHHH | 52.32 | 33845483 | |
429 | Acetylation | AKKLGKAKDLYSALI HHHHCCHHHHHHHHH | 52.32 | 12435115 | |
432 | Phosphorylation | LGKAKDLYSALIKLN HCCHHHHHHHHHHHC | 11.30 | 21406692 | |
433 | Phosphorylation | GKAKDLYSALIKLNK CCHHHHHHHHHHHCC | 24.72 | 21406692 | |
437 | Ubiquitination | DLYSALIKLNKDNLG HHHHHHHHHCCCCCC | 47.02 | 23000965 | |
440 | Ubiquitination | SALIKLNKDNLGFPV HHHHHHCCCCCCCCH | 59.43 | 23000965 | |
470 | Malonylation | LERLQALKTMKQH-- HHHHHHHHHHHCC-- | 49.98 | 26320211 | |
470 | Acetylation | LERLQALKTMKQH-- HHHHHHHHHHHCC-- | 49.98 | 25953088 | |
470 | Ubiquitination | LERLQALKTMKQH-- HHHHHHHHHHHCC-- | 49.98 | - | |
473 | Ubiquitination | LQALKTMKQH----- HHHHHHHHCC----- | 50.91 | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FACE1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FACE1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FACE1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
OST48_HUMAN | DDOST | physical | 22939629 | |
S10AA_HUMAN | S100A10 | physical | 22939629 | |
MGST3_HUMAN | MGST3 | physical | 22939629 | |
VATH_HUMAN | ATP6V1H | physical | 22939629 | |
NDUB7_HUMAN | NDUFB7 | physical | 22939629 | |
TMM43_HUMAN | TMEM43 | physical | 22939629 | |
SYJ2B_HUMAN | SYNJ2BP | physical | 22939629 | |
RAB5C_HUMAN | RAB5C | physical | 22939629 | |
GALT2_HUMAN | GALNT2 | physical | 22939629 | |
HNRPF_HUMAN | HNRNPF | physical | 22939629 | |
RT05_HUMAN | MRPS5 | physical | 22939629 | |
VDAC1_HUMAN | VDAC1 | physical | 22939629 | |
HNRL1_HUMAN | HNRNPUL1 | physical | 22939629 | |
K2013_HUMAN | KIAA2013 | physical | 22939629 | |
PTN1_HUMAN | PTPN1 | physical | 22939629 | |
RM40_HUMAN | MRPL40 | physical | 22939629 | |
RAB10_HUMAN | RAB10 | physical | 22939629 | |
CLH1_HUMAN | CLTC | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00663 | Restrictive dermopathy | |||||
H00665 | Mandibuloacral dysplasia | |||||
OMIM Disease | ||||||
608612 | Mandibuloacral dysplasia with type B lipodystrophy (MADB) | |||||
275210 | Lethal tight skin contracture syndrome (LTSCS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND MASSSPECTROMETRY. |